Table 5.

Description of control cases used for staining and expression analysis^{^a}

Control case	Age (yr)/sex	Cause of death	Autopsy interval	hR23A cytoplasm pattern	hR23A nucleus pattern	hR23B cytoplasm pattern	hR23B nucleus pattern
23 (Control Case 2 in Fig. 8)	77/M	Cardiac failure	6 h	Diffuse	Light staining	Absent	Absent
26	49/M	Cancer and obesity	4 h	Diffuse	Absent	Some reticular with weak deposits	Absent
31	67/M	Lung cancer	3.5 h	Deposits	Absent	Weak deposits	Absent
37	57/M	Cardiac arrest due to ventricular fibrillation	14 h	Deposits	Some light nuclear staining	Diffuse throughout and scattered	Absent
42	61/M	Brain tumor	6 h	Scattered throughout cytoplasm	Light staining	Deposits	Light staining
44	80/F	Liver failure	5 h	Some weak deposits	Light staining	Reticular	Absent
65	82/M	Unknown	4 h	Reticular	Present	Diffuse and reticular	Absent
67	77/M	Unknown	4 h	Reticular	Present	Deposits	Strong staining
78 (Control Case 1 in Fig. 8)	58/F	Vasculitis, cerebral hemorrhage, hepatitis C	3 h	Reticular	Absent	Reticular	Absent

↵^aThe 9 control cases from which postmortem spinal cord tissue was taken following autopsy. Control Case 1 in Figure 12A was 78 and Control Case 2 in Figure 12A was 23. Control cases in Figure 12C were loaded in Western blot in this order: 6, 23, 67, 31, 26.